(Q33436535)
Statements
1 reference
Phase I-II study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukemia (CLL): effects on T cells and immune checkpoints (English)
1 reference
Fariba Mozaffari
1 reference
Marzia Palma
1 reference
Sandra Eketorp Sylvan
1 reference
Håkan Mellstedt
1 reference
Anders Österborg
1 reference
Jeanette Lundin
1 reference
4 November 2016
1 reference
1 reference
4 November 2016
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference